PLX-200

PARAMUS, N.J. – August 25, 2026 Polaryx Therapeutics, Inc. announced continued operational progress toward initiating its SOTERIA Phase 2...

Paramus, New Jersey, USA, April 21, 2026 In a major regulatory advancement for rare disease therapeutics, Polaryx Therapeutics, Inc....